Related Experiment Video
Updated: Jul 17, 2026
13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Elevated body mass index and mortality risk in the elderly
1School of Physical and Health Education, Queen's University, Kingston, ON, Canada. janssen@post.queensu.ca
Summary
For elderly individuals, being overweight does not significantly increase mortality risk. However, moderate obesity is linked to a small rise in the risk of death, according to this meta-analysis.
Area of Science:
- Gerontology
- Public Health
- Epidemiology
Background:
- Elevated body mass index (BMI) is a growing concern in aging populations.
- Understanding the relationship between BMI and mortality risk in older adults is crucial for public health strategies.
Purpose of the Study:
- To systematically review and meta-analyze existing studies on the impact of elevated BMI on mortality risk in individuals aged 65 years and older.
- To quantify the association between overweight and obese BMI categories and all-cause mortality in the elderly.
Main Methods:
- A systematic review and variance-based meta-analysis were conducted.
- Data from 26 analyses for overweight BMI and 28 analyses for obese BMI were synthesized.
- Relative risk (RR) and 95% confidence intervals (CI) for all-cause mortality were calculated.
Main Results:
- Overweight BMI (25-29.9 kg/m²) showed no significant association with all-cause mortality in the elderly (RR = 1.00, 95% CI: 0.97-1.03).
- Obese BMI (≥30 kg/m²) was associated with a modest increase in all-cause mortality risk (RR = 1.10, 95% CI: 1.06-1.13).
Conclusions:
- Overweight BMI is not linked to increased mortality risk in older adults.
- Moderate obesity in the elderly is associated with a small but statistically significant increase in mortality risk.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...